ENGEN BIO

EnGen Bio is an independent pharmaceutical company, developing a vaccine to provide lifetime immunity to Type A influenza. Learn more... Unlike conventional flu vaccines, which are generally hemagglutinin or whole-virus based, our vaccine targets a region, a novel epitope on the flu virus's M1 matrix protein, to elicit potentially long-lasting and broadly neutralizing antibody responses in both humans and animals.

Also known as: EnGen Bio LLC